Covered recipient · General Payments record
VISHAL D DESAI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$91,810.29
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.50 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $192.59 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 1 |
| PFIZER INC. | $51.16 | 2 |
| ABBVIE INC. | $35.14 | 2 |
| Merck Sharp & Dohme Corporation | $29.38 | 1 |
| Janssen Biotech, Inc. | $27.97 | 1 |
| VIVUS LLC | $21.25 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.33 | 1 |
| EVOKE PHARMA, INC. | $18.70 | 1 |
| Lilly USA, LLC | $17.92 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.27 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103629364 | CMS |
| ABBVIE INC. | $21.87 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103629366 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146973003 | CMS |
| Boston Scientific Corporation | $181.54 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092558672 | CMS |
| Boston Scientific Corporation | $11.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092558670 | CMS |
| EVOKE PHARMA, INC. | $18.70 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127775059 | CMS |
| Intercept Pharmaceuticals, Inc. | $15.07 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113644229 | CMS |
| Janssen Biotech, Inc. | $27.97 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078578244 | CMS |
| Lilly USA, LLC | $17.92 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135440815 | CMS |
| Merck Sharp & Dohme LLC | $29.38 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141662953 | CMS |
| PFIZER INC. | $24.97 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131723562 | CMS |
| PFIZER INC. | $26.19 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131736468 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137528651 | CMS |
| VIVUS LLC | $21.25 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415450 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.